• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erratum: Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum].

出版信息

Cancer Manag Res. 2021 Aug 31;13:6797-6798. doi: 10.2147/CMAR.S336175. eCollection 2021.

DOI:10.2147/CMAR.S336175
PMID:34512019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8418365/
Abstract

[This corrects the article DOI: 10.2147/CMAR.S319048.].

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c8/8418365/2a66afbfaffe/CMAR-13-6797-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c8/8418365/2a66afbfaffe/CMAR-13-6797-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c8/8418365/2a66afbfaffe/CMAR-13-6797-g0001.jpg

相似文献

1
Erratum: Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum].
Cancer Manag Res. 2021 Aug 31;13:6797-6798. doi: 10.2147/CMAR.S336175. eCollection 2021.
2
Erratum: Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum].
Cancer Manag Res. 2021 Sep 10;13:7055-7056. doi: 10.2147/CMAR.S338286. eCollection 2021.
3
Erratum: Disulfiram Inhibits Epithelial-Mesenchymal Transition Through TGF-ERK-Snail Pathway Independently of Smad4 to Decrease Oral Squamous Cell Carcinoma Metastasis [Corrigendum].勘误：双硫仑通过TGF-ERK-蜗牛通路抑制上皮-间质转化，独立于Smad4以减少口腔鳞状细胞癌转移[勘误说明]
Cancer Manag Res. 2021 Nov 25;13:8647-8650. doi: 10.2147/CMAR.S348759. eCollection 2021.
4
Erratum: Long Noncoding RNA GAS5 Acts As A Tumor Suppressor In Laryngeal Squamous Cell Carcinoma Via miR-21 [Corrigendum].勘误：长链非编码RNA GAS5通过miR-21在喉鳞状细胞癌中作为肿瘤抑制因子[勘误]。
Cancer Manag Res. 2019 Oct 23;11:9047. doi: 10.2147/CMAR.S232421. eCollection 2019.
5
Erratum: Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage [Corrigendum].勘误：子宫颈小细胞癌的预后因素和局部治疗方式：根据国际妇产科联盟分期的分析[勘误]
Cancer Manag Res. 2020 Jul 23;12:6239. doi: 10.2147/CMAR.S272111. eCollection 2020.
6
Erratum: Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience [Corrigendum].勘误：全身化疗后使用S-1/卡培他滨对转移性鼻咽癌患者进行口服维持化疗：单机构经验[勘误]
Cancer Manag Res. 2020 Mar 31;12:2365-2366. doi: 10.2147/CMAR.S252622. eCollection 2020.
7
Erratum: Explore the Value of Adding Induction Chemotherapy to Concurrent Chemoradiotherapy in T3-4N0M0 Nasopharyngeal Carcinoma Patients: A Retrospective Study [Corrigendum].勘误：探索诱导化疗联合同步放化疗在T3-4N0M0鼻咽癌患者中的价值：一项回顾性研究[勘误]
Cancer Manag Res. 2022 May 27;14:1835-1836. doi: 10.2147/CMAR.S375850. eCollection 2022.
8
Erratum: Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum].勘误：与阿帕替尼对肝细胞癌疗效相关的药物性高血压[更正]。
Cancer Manag Res. 2020 Jun 3;12:4169-4170. doi: 10.2147/CMAR.S263933. eCollection 2020.
9
Erratum: Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum].勘误：冬凌草甲素通过靶向Akt信号通路使肝癌细胞对索拉非尼的抗癌作用敏感 [更正]
Cancer Manag Res. 2021 Mar 16;13:2515. doi: 10.2147/CMAR.S310256. eCollection 2021.
10
Erratum: Suppressing Growth and Invasion of Human Hepatocellular Carcinoma Cells by Celecoxib Through Inhibition of Cyclooxygenase-2 [Corrigendum].勘误：塞来昔布通过抑制环氧合酶-2抑制人肝癌细胞的生长和侵袭[更正]。
Cancer Manag Res. 2021 Nov 8;13:8353-8354. doi: 10.2147/CMAR.S347636. eCollection 2021.